We are global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments. For over 50 years our Group has been developing, producing and commercializing diagnostic tests: we support clinical laboratory needs and activities, providing solutions that are reliable, innovative, fully automated and standardized. We continually invest in Research & Development, using our own distinctive expertise in the field to deliver a high level of innovation.
Group Websites
Clinical Areas
We offer the broadest range of specialty tests available in the immunodiagnostics market.
Discover All Areas
Discover Our Menu
LIAISON® XS
All our technology in a new dimension.
LIAISON® XS delivers a high technology solution for immunochemistry tests that allows laboratories to improve efficiency and clinical effectiveness for routine and specialty testing.
Discover All Systems
Worldwide Presence
Our Group consists of 22 branches with offices across 5 continents and manufacturing premises producing its tests in 5 sites around the world.
Where we are
News
31/07/2023
DiaSorin launches the new LIAISON® Legionella Urinary Antigen Immunodiagnostic Assay in all countries accepting the CE Mark as an aid to the diagnosis of the Legionnaires’ Disease (LD), a life-threatening atypical Community Acquired Pneumonia (CAP).
Read the press release
13/06/2023
DiaSorin launches the LIAISON® BRAHMS MR-proADM™ assay in all countries accepting the CE mark to improve patient management by providing the assessment of disease severity
Read the press release
07/05/2023
Euromeadlab 2023: we look forward to seeing you at our booth #120 and at our EDU Workshop 5 "New testing solutions to enhance patient management in specialized infection at the Emergency Department admission” on 22/05/23 14.30-15.30
30/09/2022
Delta Cure 2022: We look forward to seeing you at our booth #3. October 6-7, 2022 - Milan, Italy - Cloisters of San Barnaba